Rationale: The recessive form of catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in the cardiac calsequestrin gene (CASQ2): this variant of CPVT is less well characterized than the autosomal dominant form caused by mutations in the RyR2 gene. Objective: We characterized intracellular Ca2+ homeostasis, electrophysiological properties and the ultrastructural features of the Ca2+ release units (CRUs) in the homozygous R33Q knock-in mouse model. Methods and Results: We studied isolated R33Q and wild-type (WT) ventricular myocytes and observed properties not previously identified in a CPVT model. As compared to WT cells, R33Q myocytes: 1) show spontaneous Ca2+ waves unable to propagate as cell-wide waves; 2) show smaller Ca2+ sparks with shortened coupling intervals suggesting a reduced refractoriness of Ca2+ release events; 3) have a reduction of the area of membrane contact and the of junctions between jSR and T-tubules (couplons) and of jSR volume; 4) have a propensity to develop phase 2-4 afterdepolarizations that can elicit triggered beats 5) Viral gene transfer with WT CASQ2 is able to normalize structural abnormalities and restore cell-wide calcium wave propagation. Conclusions: Our data show that homozygous CASQ2-R33Q myocytes develop spontaneous Ca2+ release events with a broad range of intervals coupled to preceding beats leading to the formation of early and delayed afterdepolarizations. They also display a major disruption of the CRU architecture that leads to fragmentation of spontaneous Ca2+ waves. We propose that these two substrates in R33Q myocytes synergize to provide a new arrhythmogenic mechanism for CPVT.

Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia.

Napolitano C;PRIORI, SILVIA GIULIANA
2013-01-01

Abstract

Rationale: The recessive form of catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in the cardiac calsequestrin gene (CASQ2): this variant of CPVT is less well characterized than the autosomal dominant form caused by mutations in the RyR2 gene. Objective: We characterized intracellular Ca2+ homeostasis, electrophysiological properties and the ultrastructural features of the Ca2+ release units (CRUs) in the homozygous R33Q knock-in mouse model. Methods and Results: We studied isolated R33Q and wild-type (WT) ventricular myocytes and observed properties not previously identified in a CPVT model. As compared to WT cells, R33Q myocytes: 1) show spontaneous Ca2+ waves unable to propagate as cell-wide waves; 2) show smaller Ca2+ sparks with shortened coupling intervals suggesting a reduced refractoriness of Ca2+ release events; 3) have a reduction of the area of membrane contact and the of junctions between jSR and T-tubules (couplons) and of jSR volume; 4) have a propensity to develop phase 2-4 afterdepolarizations that can elicit triggered beats 5) Viral gene transfer with WT CASQ2 is able to normalize structural abnormalities and restore cell-wide calcium wave propagation. Conclusions: Our data show that homozygous CASQ2-R33Q myocytes develop spontaneous Ca2+ release events with a broad range of intervals coupled to preceding beats leading to the formation of early and delayed afterdepolarizations. They also display a major disruption of the CRU architecture that leads to fragmentation of spontaneous Ca2+ waves. We propose that these two substrates in R33Q myocytes synergize to provide a new arrhythmogenic mechanism for CPVT.
2013
Cardiovascular & Hematology Research covers all levels of investigation into the normal and pathogenic functions of the heart, vasculature, and soluble blood components. Cell biology of vascular tissue and formed elements of blood, biochemical regulation of thrombosis, therapeutic strategies for treatment of cardiac and vascular diseases are also considered. Resources on hematologic oncology are excluded and are placed in the Oncogenesis & Cancer Research category.
Esperti anonimi
Inglese
Internazionale
ELETTRONICO
113
2
142
152
11
Calsequestrin; arrhythmia (mechanisms); calcium regulation; electrophysiology; functional recovery; gene transfer; genetics
8
info:eu-repo/semantics/article
262
Liu, N; Denegri, M; Dun, W; Boncompagni, S; Lodola, F; Protasi, F; Napolitano, C; Boyden, P; Priori, SILVIA GIULIANA
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/688630
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 43
social impact